BioVentureHub

AstraZeneca's BioVentureHub is a unique business innovation experiment and public-private-partnership model. AstraZeneca has opened up its Gothenburg R&D site and 33 life science companies and organisations are co-locating and collaborating with the global pharma company. They gain unique access to AstraZeneca's world-class knowledge, capabilities and infrastructure. By daring to share and stimulating a 4D life science reality - combining Drugs, Devices (MedTech), Diagnostics & Digital Health - we are forming a modern life science environment based on scientific curiosity, innovation and collaboration opportunities, rather than strict business plans and financial outcomes. "AstraZeneca's BioVentureHub is an exciting innovation model for strengthening competitiveness in the life science industry. It's smart Swedish industry in action, serving as inspiration to other companies and industries when it comes to generating opportunities in the new industrial era."​ -Mikael Damberg, fmr Swedish Minister for Enterprise and Innovation